Pritesh Shah - Jul 31, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Commercial Officer
Signature
By: /s/ Steven Robbins, Attorney in fact for Pritesh Shah
Stock symbol
NVCR
Transactions as of
Jul 31, 2021
Transactions value $
$311,259
Form type
4
Date filed
3/11/2022, 03:54 PM
Previous filing
Jul 8, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $572K +3.72K +4.54% $154.01* 85.6K Jul 31, 2021 Direct
transaction NVCR Ordinary Shares Sale -$261K -3.67K -4.22% $71.19 83.2K Mar 9, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Restricted Stock Units Options Exercise $0 -3.72K -50% $0.00 3.72K Jul 31, 2021 Ordinary Shares 3.72K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
F2 Amended total to correct prior mathematical error.
F3 Fully vested as of the date hereof.